Volume 59, Issue 5, Pages (May 2001)

Slides:



Advertisements
Similar presentations
Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Advertisements

Pattern of Growth in Children with Cerebral Palsy
The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease  Ryo Matsuura, Kenjiro.
Volume 62, Issue 2, Pages (August 2002)
Volume 66, Issue 6, Pages (December 2004)
Volume 71, Issue 1, Pages (January 2007)
Volume 81, Issue 11, Pages (June 2012)
Current status of end-stage renal disease care in India and Pakistan
Volume 58, Issue 4, Pages (October 2000)
Current status of end-stage renal disease care in India and Pakistan
Hepatic Cysts in Autosomal Dominant Polycystic Kidney Disease
Alex Castellarnau, Michael Werner, Roman Günthner, Marten Jakob 
Robert W. Schrier, Kimberly K. McFann, Ann M. Johnson 
Hepatic Cysts in Autosomal Dominant Polycystic Kidney Disease
Nat. Rev. Nephrol. doi: /nrneph
Burden of chronic kidney disease: North Africa
Vascular access surveillance: an ongoing controversy
Statistical limitations of percent ideal body weight as measure for nutritional failure in patients with cystic fibrosis  T.O. Hirche, H. Hirche, S. Jungblut,
Volume 68, Issue 3, Pages (September 2005)
Figure 6 Hypothetical effect of starting therapy for autosomal
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 71, Issue 1, Pages (January 2007)
Volume 82, Issue 10, Pages (November 2012)
Volume 65, Issue 2, Pages (February 2004)
Comorbidity and confounding in end-stage renal disease
Gregory B. Vanden Heuvel  Kidney International 
Further evidence for linkage of autosomal-dominant medullary cystic kidney disease on chromosome 1q21  Mari Auranen, Sirpa Ala-Mello, Joni A. Turunen,
Volume 70, Issue 11, Pages (December 2006)
Volume 74, Issue 9, Pages (November 2008)
Volume 65, Issue 2, Pages (February 2004)
Volume 70, Issue 12, Pages (December 2006)
Blood pressure targets in hemodialysis patients
Fructose intake as a risk factor for kidney stone disease
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Copyright © 2013 Elsevier Inc. All rights reserved.
Volume 71, Issue 6, Pages (March 2007)
Hans Pottel, Laurence Dubourg, Karolien Goffin, Pierre Delanaye 
Volume 81, Issue 9, Pages (May 2012)
Volume 81, Issue 4, Pages (February 2012)
Volume 66, Issue 2, Pages (August 2004)
Volume 79, Issue 1, Pages (January 2011)
Circadian regulation of renal function
Homocysteine, renal function, and risk of cardiovascular disease
Volume 67, Issue 2, Pages (February 2005)
Volume 53, Issue 5, Pages (May 1998)
Volume 63, Issue 5, Pages (May 2003)
Volume 81, Issue 11, Pages (June 2012)
Volume 76, Issue 6, Pages (September 2009)
This Month in AJKD American Journal of Kidney Diseases
Volume 61, Issue 3, Pages (March 2002)
Robert G. Nelson, Hal Morgenstern, Peter H. Bennett 
Is it the low-protein diet or simply the salt restriction?
Is complement a target for therapy in renal disease?
Molecular and structural consequences of early renal allograft injury
Assessing the impact of different imputation methods on serial measures of renal function: The Strong Heart Study  N.-M. Shara, J.-G. Umans, W. Wang,
Chi-Yuan Hsu, M.D., M.Sc., Glenn M. Chertow, Gary C. Curhan 
Volume 53, Issue 6, Pages (June 1998)
Volume 72, Issue 11, Pages (December 2007)
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children  G.J. Schwartz, S. Furth, S.R. Cole, B.
Volume 65, Issue 2, Pages (February 2004)
Volume 67, Issue 4, Pages (April 2005)
Volume 68, Issue 5, Pages (November 2005)
Volume 56, Issue 3, Pages (September 1999)
Volume 64, Issue 3, Pages (September 2003)
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
The pretest probability of disease decreases with age in individuals who are born with 50% risk for autosomal dominant polycystic kidney disease (ADPKD)
Volume 60, Issue 1, Pages (July 2001)
Presentation transcript:

Volume 59, Issue 5, Pages 1654-1662 (May 2001) Progression of autosomal-dominant polycystic kidney disease in children1  Godela M. Fick-Brosnahan, Zung Vu Tran, Ann M. Johnson, John D. Strain, Patricia A. Gabow  Kidney International  Volume 59, Issue 5, Pages 1654-1662 (May 2001) DOI: 10.1046/j.1523-1755.2001.0590051654.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Ultrasound findings and gene linkage analysis (GLA) results in the study children (1985 to 1999). Abbreviations are: US, ultrasound; GLA, gene linkage analysis; NA, not available; +, positive; -, negative. Kidney International 2001 59, 1654-1662DOI: (10.1046/j.1523-1755.2001.0590051654.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Ultrasound findings in 185 autosomal dominant polycystic kidney disease (ADPKD) children at their first visit and at follow-up. Abbreviations are: US, ultrasound; GLA, gene linkage analysis. Kidney International 2001 59, 1654-1662DOI: (10.1046/j.1523-1755.2001.0590051654.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Relationship between mean renal volume (MRV; cm3) and age (years) in 182 affected (solid line; ultrasound-positive) and 127 unaffected (dashed line) children who had one to four visits before the age of 20 years. The regression model that gave the best fit for the data was the growth model. The equation for the affected children is MRV = e3.679+0.103×age, with R2 = 0.61; for the unaffected children MRV = e3.399+0.095×age, with R2 = 0.77. The β coefficients of the growth curves differ significantly (1.38 vs. 1.05; P < 0.001) between the affected and unaffected children, with the curve for the affected children being steeper, indicating that renal volume increases faster over time in the affected than the unaffected children. Kidney International 2001 59, 1654-1662DOI: (10.1046/j.1523-1755.2001.0590051654.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 (A) Scatter plot of individual MRV in affected children according to age. The growth model is represented by the black dots, whereas the actual data are plotted in gray. (B) Scatter plot of individual MRV in unaffected children according to age. The growth model is represented by the black dots, whereas the actual data are plotted in gray. Kidney International 2001 59, 1654-1662DOI: (10.1046/j.1523-1755.2001.0590051654.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 (A) Relationship between MRV normalized for height and age in 46 unaffected boys (solid line) and 81 unaffected girls (dashed line). The equation for boys is: MRV = e3.937+0.051×age, with R2 = 0.45; for girls MRV = e3.862+0.049×age, with R2 = 0.57. The curves and the β coefficients (0.97 vs. 0.81 for boys vs. girls) are not significantly different, indicating that the height-normalized MRV of unaffected boys and girls are similar and increase at a similar rate (the same is true when MRV are not normalized for height). (B) Relationship between MRV normalized for height and age in 90 affected boys and 92 affected girls. The equation for boys is: MRV = e4.246+0.048×age, with R2 = 0.27; for girls MRV = e4.089+0.065×age, with R2 = 0.34. The curves and the β coefficients (0.67 vs. 0.58 for boys vs. girls) are not significantly different, indicating that the height-normalized MRV of affected boys and girls are similar and increase at a similar rate (the same is true when MRV are not normalized for height). Kidney International 2001 59, 1654-1662DOI: (10.1046/j.1523-1755.2001.0590051654.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 6 Mean renal volume according to age in 108 ADPKD children who had two or more visits before age 20 years, separated into curves for 30 children with early severe disease (—) and 78 children who did not have early severe disease (--). For the “early severe” children MRV = e3.863+0.131×age, R2 = 0.89. For the children with mild disease MRV = e3.395+0.107×age, R2 = 0.79. The β coefficients of the curves were significantly different (1.74 vs. 1.40, P < 0.05), with the curve of the early severe children being significantly steeper, indicating significantly faster renal growth. Kidney International 2001 59, 1654-1662DOI: (10.1046/j.1523-1755.2001.0590051654.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 7 Mean renal volume according to age in 33 ADPKD children with blood pressures above the 75th percentile at the first and last visit (HBP 75; —) and 37 ADPKD children with blood pressures below the 75th percentile at both visits (NBP; --). For the HBP 75 children MRV = e3.765+0.107×age, with R2 = 0.65; for the NBP children MRV = e3.570+0.099×age, with R2 = 0.70. The β coefficients of the curves were significantly different (1.22 vs. 1.11, P < 0.05), with the curve of the HBP 75 children being significantly steeper, indicating significantly faster renal growth than the NBP children. Kidney International 2001 59, 1654-1662DOI: (10.1046/j.1523-1755.2001.0590051654.x) Copyright © 2001 International Society of Nephrology Terms and Conditions